| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | MEDP | Common Stock | Sale | -$41.3M | -100K | -2.03% | $412.98 | 4.83M | Mar 6, 2024 | Direct | F1, F2 |
| transaction | MEDP | Common Stock | Sale | -$30.8M | -75K | -1.55% | $410.74 | 4.76M | Mar 7, 2024 | Direct | F1, F3 |
| transaction | MEDP | Common Stock | Sale | -$10.2M | -25K | -0.53% | $408.71 | 4.73M | Mar 8, 2024 | Direct | F1, F4 |
| Id | Content |
|---|---|
| F1 | The transactions reported on this Form 4 were effected pursuant to a limit order placed by the Reporting Person during an open window period. |
| F2 | The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $406.36 to $419.42. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request. |
| F3 | The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $406.33 to $415.64. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request. |
| F4 | The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $402.90 to $414.195. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request. |